Abstrakt

Przypisy

• 1. Bandyopadhyay D., Mishra A., Medrano E.E.: Overexpression of histonedeacetylase 1 confers resistance to sodium butyrate-mediatedapoptosis in melanoma cells through a p53-mediated pathway. CancerRes., 2014, 64: 7706-7710
  Google Scholar
• 2. Bębenek E., Chodurek E., Orchel A., Dzierżewicz Z., Boryczka S.: Antiproliferativeactivity of novel acetylenic derivatives of betulin againstG-361 human melanoma cells. Acta Pol. Pharm.-Drug Res., 2015, 72:699-703 3 Bertolotto C.: Melanoma: from melanocyte to genetic alterationsand clinical options. Scientifica, 2013, 2013: 635203
  Google Scholar
• 3. promotes surviving melanoma tumour cell growth after cytotoxictherapy. J. Invest. Dermatol., 2014, 134: 1686-1692
  Google Scholar
• 4. Boryczka S., Bębenek E., Wietrzyk J., Kempińska K., Jastrzębska M.,Kusz J., Nowak M.: Synthesis, structure and cytotoxic activity of newacetylenic derivatives of betulin. Molecules, 2013, 18: 4526-4543
  Google Scholar
• 5. Bradford M.M.: A rapid and sensitive method for the quantitation ofmicrogram quantities of protein utilizing the principle of protein-dyebinding. Anal. Biochem., 1976; 72: 248-254
  Google Scholar
• 6. Chudzik M., Korzonek-Szlacheta I., Król W.: Triterpenes as potentiallycytotoxic compounds. Molecules, 2015, 20: 1610-1625
  Google Scholar
• 7. Donato A.L., Huang Q., Liu X., Li F., Zimmerman M.A., Li C.Y.: Caspase
  Google Scholar
• 8. Freeman-Keller M., Weber J.S.: Anti-programmed death receptor 1immunotherapy in melanoma: rationale, evidence and clinical potential.Ther. Adv. Med. Oncol., 2015, 7: 12-21
  Google Scholar
• 9. Fulda S.: Targeting apoptosis signaling pathways for anticancertherapy. Front. Oncol., 2011, 1: 23
  Google Scholar
• 10. Fulda S., Debatin K.M.: Extrinsic versus intrinsic apoptosis pathwaysin anticancer chemotherapy. Oncogene, 2006, 25: 4798-4811
  Google Scholar
• 11. Fung K.Y., Cosgrove L., Lockett T., Head R., Topping D.L.: A reviewof the potential mechanisms for the lowering of colorectal oncogenesisby butyrate. Br. J. Nutr., 2012, 108: 820-831
  Google Scholar
• 12. Girouard S.D., Laga A.C., Mihm M.C., Scolyer R.A., Thompson J.F.,Zhan Q., Widlund H.R., Lee C.W., Murphy G.F.: Sox2 contributes to melanomacell invasion. Lab. Invest., 2012, 92: 362-370
  Google Scholar
• 13. Kim Y.J., Lee J.B., Kim S.J., Lee S.C., Won Y.H., Yun S.J.: Amelanoticacral melanoma associated with KIT mutation and vitiligo. Ann. Dermatol.,2015, 27: 201-205
  Google Scholar
• 14. Kommera H., Kaluderović G.N., Kalbitz J., Paschke R.: Synthesis andanticancer activity of novel betulinic acid and betulin derivatives. Arch.Pharm., 2010, 343: 449-457
  Google Scholar
• 15. Król S.K., Kiełbus M., Rivero-Müller A., Stepulak A.: Comprehensivereview on betulin as a potent anticancer agent. Biomed. Res. Int.,2015, 2015: 584189
  Google Scholar
• 16. McClain S.E., Mayo K.B., Shada A.L., Smolkin M.E., Patterson J.W.,Slingluff C.L. Jr.: Amelanotic melanomas presenting as a red skin lesions:a diagnostic challenge with potentially lethal consequences. Int.J. Dermatol., 2012, 51: 420-426
  Google Scholar
• 17. Nohara K., Yokoyama Y., Kano K.: The important role of caspase-10in sodium butyrate-induced apoptosis. Kobe J. Med. Sci., 2007, 53: 265-273
  Google Scholar
• 18. Orchel A., Kulczycka A., Chodurek E., Bębenek E., Borkowska P.,Boryczka S., Kowalski J., Dzierżewicz Z.: Influence of betulin and 28-Opropynoylbetulinon proliferation and apoptosis of human melanomacells (G-361). Postępy Hig. Med. Dośw., 2014, 68: 191-198
  Google Scholar
• 19. Pfarr K., Danciu C., Arlt O., Neske C., Dehelean C., PfeilschifterJ.M., Radeke H. H.: Simultaneous and dose dependent melanoma cytotoxicand immune stimulatory activity of betulin. PLoS One, 2015,10: e0118802
  Google Scholar
• 20. Photiou A., Sheikh M.N., Bafaloukos D., Retsas S.: Antiproliferativeactivity of vinorelbine (Navelbine) against six human melanoma celllines. J. Cancer Res. Clin. Oncol., 1992, 118: 249-254
  Google Scholar
• 21. Slominski A., Zbytek B., Slominski R.: Inhibitors of melanogenesisincrease toxicity of cyclophosphamide and lymphocytes against melanomacells. Int. J. Cancer, 2009, 124: 1470-1477
  Google Scholar
• 22. Uong A., Zon L.I.: Melanocytes in development and cancer. J. Cell.Physiol., 2010, 222: 38-41
  Google Scholar

Pełna treść artykułu